| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |